Life expectancy in Gaucher disease type 1

American Journal of Hematology

Volumn 83, Issue 12, 2008, Pages 896-900

  Weinreb, Neal J ^a   Deegan, Patrick ^b   Kacena, Katherine A ^c,g   Mistry, Pramod ^d   Pastores, Gregory M ^e   Velentgas, Priscilla ^c,h   Vom Dahl, Stephan ^f  

^a University Research Foundation for Lysosomal Storage Diseases   (United States)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c GENZYME CORPORATION   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF COLOGNE   (Germany)

^g A Subsidiary of Lantheus Holdings   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CAUSE OF DEATH; CHILD; FEMALE; GAUCHER DISEASE; HUMAN; INFANT; LIFE EXPECTANCY; LIFE TABLE METHOD; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PRIORITY JOURNAL; REGISTER; SPLENECTOMY; SURVIVAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; EUROPE; FEMALE; GAUCHER DISEASE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; LIFE EXPECTANCY; MALE; MIDDLE AGED; REGISTRIES; SPLENECTOMY; UNITED STATES; YOUNG ADULT;

EID: 56749172489     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21305     Document Type: Article

References (24)

1. Grabowski G, Kolodny E, Weinreb N, et al.Gaucher disease: Phenotypic and genetic variation. In: Scriver CR, Beaudet A, Valle D, Slye WS, editors. The Online Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill; 2006.Chapter 146.1. Available from: http://genetics.accessmedicine. com/serverjava/Arknoid/amed/mmbic/co_chapters/ch146.1/ch146.1_p01.html Accesed March 31, 2008.
2. Rosenbloom BE, Weinreb NJ, Zimran A, et al. Gaucher disease and cancer incidence: A study from the Gaucher Registry. Blood 2005;105:4569-4572.
3. Zimran A, Liphshitz I, Barchana M, et al. Incidence of malignancies among patients with Gaucher disease type 1 from a single referral clinic. Blood Cells Mol Dis 2005;34:197-200.
4. de Fost M, vom Dahl S, Weverling GJ, et al. Increased incidence of cancer in adult Gaucher disease in Western Europe. Blood Cells Mol Dis 2006;36:53-58.
5. Charrow J, Andersson HC, Kaplan P, et al. The Gaucher Registry: demographics and disease characteristics of 1698 patients with Gaucher disease. Arch Intern Med 2000;160:2835-2843.
6. Giraldo P, Solano V, Perez-Calvo J-I, et al., Spanish Group on Gaucher disease. Quality of life related to Gaucher disease type 1: Spanish experience. Qual Life Res 2005;14:453-461.
7. Weinreb NJ, Charrow J, Andersson HC, et al. Effectiveness of enzyme replacement therapy in 1028 patients with Gaucher disease type 1 after 2 to 5 years of treatment: a report from the Gaucher Registry. Am J Med 2002;113:112-119.
8. Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N Engl J Med 2004;351:1972-1977.
9. Itokawa K, Tamura N, Kawai N, et al. Parkonsinism in type 1 Gaucher's disease. Intern Med 2006;45:1165-1167.
10. Zimran A, Kay A, Gelbart T, et al. Gaucher disease: Clinical, laboratory, radiologic, and genetic features of 53 patients. Medicine (Baltimore) 1992;71:337-353.
11. Lachmann RH, Wight DG, Lomas DJ, et al. Massive hepatic fibrosis in Gaucher's disease: Clinico-pathological and radiological features. Q J Med 2000;93:237-244.
12. Ashkenazi A, Zaizov R, Matoth Y. Effect of splenectomy on destructive bone changes in children with chronic (Type I) Gaucher disease. Eur J Pediatr 1986;145:138-141.
13. Fleshner PR, Aufses AH,Jr. Grabowski GA, Elias R. A 27-year experience with splenectomy for Gaucher's disease. Am J Surg 1991;161:69-75.
14. Mistry PK, Sirrs S, Chan A, et al. Pulmonary hypertension in type 1 Gaucher's disease: Genetic and epigenetic determinants of phenotype and response to therapy. Mol Genet Metab 2002;77:91-98.
15. Baron Duffy ML. Trends in median age at death: New Jersey, 1970-2000. Topics in Health Statistics. 2004 Available from: http://www.state.nj.us/health/ chs. Accessed July 13, 2007.
16. Minino AM, Heron MP, Smith BL. Deaths: Preliminary data for 2004. National Vital Statistics Reports 2006;54:1-50.
17. Ginsberg H, Grabowski GA, Gibson JC, et al. Reduced plasma concentrations of total, low density lipoprotein and high density lipoprotein cholesterol in patients with Gaucher type I disease. Clin Genet 1984;26:109-116.
18. Corssmit EPM, Hollak CEM, Endert E, et al. Increased basal glucose production in type 1 Gaucher's disease. J Clin Endocrinol Metab 1995;80:2653-2657.
19. Langeveld M, Ghauharali KJM, Sauerwein HP, et al. Gaucher disease type 1, a glycosphingolipid storage disorder, is associated with insulin resistance. J Clin Endocrinol Metab 2008;93:845-851.
20. Langeveld M, Scheij S, Dubbelhuis P, et al. Very low serum adiponectin levels in patients with Gaucher disease type 1 without overt hyperglycemia. Metabolism 2007;56:314-319.
21. Allen MJ, Myer BJ, Khokher AM, et al. Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10. Q J Med 1997;90:19-25.
22. Palmore JA, Gardner RW. Measuring Mortality, Fertility and Natural Increase - A Self-Teaching Guide to Elementary Measures. Honolulu: East-West Center; 1996.
23. Rothman K. Epidemiology: An Introduction. New York: Oxford University Press; 2002.
24. World Population Prospects, 2002, UN. Available from :http://www.un.org/ esa/population/publications/wpp2002/WPP2002-HIGHLIGHTSrev1.PDF. Accessed on July 13, 2007.